Clinical Trials on Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors
Total 9248 results
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingNeurofibromatosis Type 1 | Metastatic Malignant Peripheral Nerve Sheath Tumor | Recurrent Malignant Peripheral Nerve Sheath TumorUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.TerminatedNeurofibromatosis and Malignant Peripheral Nerve Sheath TumorsChina
-
Johns Hopkins UniversityRecruitingNeurofibromatosis 1 | Atypical Neurofibroma | Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis)United States
-
Sarcoma Alliance for Research through CollaborationNational Cancer Institute (NCI)CompletedSarcoma | Neurofibromatosis Type 1United States
-
National Cancer Institute (NCI)Active, not recruitingNeurofibroma | Neurofibromatosis Type 1 | Malignant Peripheral Nerve Sheath Tumor | Optic Glioma | Plexiform NeurofibromaUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis 1 | Peripheral Nerve Neoplasms, MalignantUnited States
-
Oslo University HospitalMerck Sharp & Dohme LLCTerminatedMalignant Peripheral Nerve Sheath Tumour (MPNST)Norway
-
National Cancer Institute (NCI)CompletedNeurofibromatosis | MPNSTUnited States
-
Sarcoma Alliance for Research through CollaborationUnited States Department of Defense; AstraZenecaCompletedNeurofibromatosis 1 | Malignant Peripheral Nerve Sheath TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterAstex Pharmaceuticals, Inc.RecruitingMalignant Peripheral Nerve Sheath Tumors (MPNST)United States
-
Universitaire Ziekenhuizen KU LeuvenUnknownMagnetic Resonance Imaging | Neurofibromatosis 1 | Whole Body Imaging | Diffusion Magnetic Resonance Imaging | Peripheral Nerve Sheath Tumors, MalignantBelgium
-
KU LeuvenUnknownNeurofibromatosis Type 1Belgium
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | NF1 Mutation Positive Malignant Peripheral Nerve Sheath TumorUnited States
-
M.D. Anderson Cancer CenterRecruitingRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Recurrent Rhabdomyosarcoma | Refractory Neuroblastoma | Refractory Rhabdomyosarcoma | Desmoplastic Small Round Cell Tumor | Recurrent Malignant Peripheral Nerve Sheath Tumor | Ewing Sarcoma/Peripheral... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterWashington University School of Medicine; University of California, Los Angeles and other collaboratorsTerminatedSarcoma | Leiomyosarcoma | Malignant Peripheral Nerve Sheath Tumor | Malignant Fibrous | Histiocytoma/Undifferentiated Pleomorphic SarcomaUnited States
-
AdaptimmuneRecruitingOsteosarcoma | Neuroblastoma | Synovial Sarcoma | Malignant Peripheral Nerve Sheath Tumor (MPNST)United States
-
Memorial Sloan Kettering Cancer CenterBayerCompletedSarcoma | Leiomyosarcoma | Malignant Peripheral Nerve Sheath Tumor | Synovial SarcomaUnited States
-
Nicole BacaRecruiting
-
University of FloridaEpizyme, Inc.RecruitingPeripheral Nerve Sheath TumorUnited States
-
Sarcoma Alliance for Research through CollaborationUnited States Department of Defense; Synta Pharmaceuticals Corp.CompletedSarcoma | Malignant Peripheral Nerve Sheath Tumors (MPNST)United States
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationCompletedNeurofibromatosis Type IIUnited States
-
Case Comprehensive Cancer CenterTerminatedGlioma | Brain Tumor | Neurofibromatosis Type 1United States
-
Massachusetts Eye and Ear InfirmaryRecruiting
-
National Institute of Neurological Disorders and...Recruiting
-
Leiden University Medical CenterRecruiting
-
Guy's and St Thomas' NHS Foundation TrustCompletedNeurofibromatosis 2United Kingdom
-
FDA Office of Orphan Products DevelopmentCompletedNeurofibromatosis 2United States
-
Manchester University NHS Foundation TrustCompletedNeurofibromatosis Type 2United Kingdom
-
PTC TherapeuticsUnited States Department of DefenseTerminated
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosis | Neurofibromatosis 2 | Schwannomatosis | Neurofibromatosis IUnited States
-
National Cancer Institute (NCI)Not yet recruitingNeurofibromatosis 1 | Nerve Sheath NeoplasmsUnited States
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosis 2United States
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaboratorsTerminatedNeurofibromatosis Type 1 (NF1)United States, Canada
-
Medical University of ViennaMedical University of Graz; Charite University, Berlin, Germany; Hannover Medical... and other collaboratorsCompletedSarcoma | Hematologic Diseases | Leukemia | Brain Tumor | Neurofibromatoses | NeuroblastomaAustria, Germany, Switzerland, Italy
-
Virginia Commonwealth UniversityCompletedNeurofibromatosis 1 | Neurocognitive Deficit | Mental Health ImpairmentUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | Neurofibromatosis Type 1Canada, United States
-
Washington University School of MedicineCompletedDoxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue SarcomaSoft Tissue Sarcoma | Sarcoma, Soft Tissue | Leiomyosarcoma | Fibrosarcoma | Liposarcoma | Angiosarcoma | Malignant Peripheral Nerve Sheath Tumor | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Epithelioid Sarcoma | MyxofibrosarcomaUnited States
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | Cutaneous Neurofibroma | Neurofibromatosis (Nonmalignant)United States
-
Roger PackerWithdrawnNeurofibromatosis Type 1 | Tumors of the Central Nervous SystemUnited States
-
University of Texas Southwestern Medical CenterWithdrawnPeripheral Nerve TumorsUnited States
-
National Cancer Institute (NCI)RecruitingColorectal Neoplasms | Advanced Breast Cancer | Advanced Solid Tumors | Malignant Peripheral Nerve Sheath Tumor | Metastatic Pancreatic Cancer | Pediatric Solid TumorUnited States
-
AstraZenecaRecruitingNeurofibromatosis Type 1Portugal, Spain, United Kingdom, Israel, France, Italy, Switzerland, Germany, Austria
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingType I NeurofibromatosisChina
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Legius SyndromeUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedNeurofibromatosis Type 1France
-
Children's National Research InstituteEmory University; University of Texas Southwestern Medical Center; Arizona State...Completed
-
Shriners Hospitals for ChildrenUniversity of Utah; Thrasher Research FundCompletedNeurofibromatosis Type 1United States
-
University Hospital, ToulouseUnknownNeurofibromatosis Type 1France
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... and other collaboratorsCompletedNeurofibromatosis Type 1United States, Australia